RSS Feed
May 7th, 2016 
Awake Goy
Susanne Posel ,Chief Editor Occupy Corporatism | Media Spokesperson, HEALTH MAX Brands
Zombies are the stuff of legends and alternative media websites; however BIoQuark, a biotech corporation based in the US, is trying to do the impossible – bring a brain-dead patient back to life.
With the blessing from the US Institutional Review Board, BioQuark is beginning its first run of trials which includes the initial stages of the ReAnima project.
This is an endeavor to identify 20 residents from India who are legally and clinically dead under the Uniform Determination of Death Act (UDDA) criteria who will participate in reversing this state of non-existence.
This concept of clinical death was created in 1968 with the publication of a report by of the Ad Hoc Committee of the Harvard Medical School to Examine the Definition of Death , who redefined “irreversible coma”. The report also gave doctors the ability to declare a person dead in just a few minutes.
For a large majority of the medical establishment in years past, the definition of death was the patient’s loss of personhood and not necessarily defined by a heart that could not be restarted.
The Harvard authors defined a “permanently non-functioning brain” as:
• Unreceptively or unresponsitivity to “even the most painful stimuli”
• No movements or spontaneous breathing
• No reflexes
• Flat EEG
The results, according to the committee must be repeated 24 hours later to prove the patient was deceased. The only acceptations were hypothermia and drug intoxication because they can mimic conditions similar to death.
The criterion, set forth by the Harvard committee, was not based on any observations from patients, experiments on humans or animals.
Then in 1981, the UDDA was approved by the National Conference of Commissioners on Uniform State Laws was based on the Harvard committee document.
Within 13 years, all 50 states in the US codified this 4 page article as the definition of clinical death.
The mainstream medical community assumes that the brain controls bodily functionality.
D. Alan Shewmon , pediatric neurologist at UCLA, rejects this idea.
Shewmon believes the definition of clinical death needs revision. He says “that most integrative functions of the brain are actually not somatically integrating, and, conversely, most integrative functions of the body are not brain-mediated.”
In a 150 page document, Shewmon explains brain-dead patients still have heart beats. In one case, a patient survived more than 2 decades after brain death.
In the first round of trials, BioQuark hopes to utilize “permutation of stem cells, peptide extracts, lasers and nerve stimulators” in an attempt to convince the cells to “differentiate properly”.
In a press release , the company is unclear as to whether or not they will use lasers to coax “still-viable brain tissue to repair or regrow axons” or simply “implant stem cells in such tissue, or to start with stem cells in vitro and grow a matrix and then implant”, but any movement forward would be an achievement.
Ira Pastor, chief executive officer for BioQuark, explained: “This represents the first trial of its kind and another step towards the eventual reversal of death in our lifetime. To undertake such a complex initiative, we are combining biologic regenerative medicine tools with other existing medical devices typically used for stimulation of the central nervous system, in patients with other severe disorders of consciousness. We hope to see results within the first two to three months.”
Related Posts
Source Article from http://feedproxy.google.com/~r/OccupyCorporatism/~3/8Ln2ZXndeBo/
Posted in 
Tags: 
